The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Veriheal

JUNE 22, 2020

Whether or not cannabis use during pregnancy causes physical, cognitive, or mental impairments later in life has been something scientists and researchers have been investigating for decades. Unfortunately, much of the research conducted thus far have not shown the whole picture or clinical implications for children in real life.

Research and Development 98

Research and Development Data Policy Education 98

Veriheal

JANUARY 31, 2023

Despite the fact that the legal cannabis industry is growing, many people are still purchasing from the illicit market. A recent study investigated this matter and found that buying cannabis from the illicit market may be “better” than legal weed. But what about the risks that come with illicit cannabis?

Legalization 104

Legalization Research and Development Business Cannabis 104

NewsMunchies

JULY 10, 2023

Artificial intelligence is a smarter, faster, and more effective pathway to drug development. With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds major potential to increase the accessibility of drugs and to treat diseases and conditions.

Treatment 58

Treatment Research and Development Pharmaceutical Microdosing 58

Veriheal

MAY 18, 2023

Nonetheless, guidelines pertaining to the use of cannabis-based treatments for chronic pain relief have been somewhat hazy…up until now. New guidelines for cannabis in chronic pain were recently published by a group of Canadian researchers. How Were the New Guidelines for Cannabis in Chronic Pain Developed?

Chronic Pain 98

Chronic Pain Treatment Research and Development Patients 98

Cannabis Law Report

JUNE 18, 2021

CanMar Recruitment is looking for a Director of Business Development and Partnerships for our client in Montreal, Quebec. As Director of Business Development and Partnerships, you are responsible for leading and accelerating business analysis, sourcing, and deal flow activities. About Our Client. About the Role. Responsibilities.

Business 104

Business Research and Development Advocacy Data 104

Cannabis Law Report

AUGUST 1, 2021

Unfortunately, on the negative side, Connecticut yet again extended the 10% surcharge on the corporation business tax, and delayed and extended the phase-out of the capital base tax on corporations.

Research and Development 105

Research and Development Programs Legislation Business 105

Veriheal

APRIL 11, 2022

Cannabis, despite being widely available for medical and recreational consumers across the United States, remains one of the most understudied plants. federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Fortunately, the U.S. territories.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

APRIL 28, 2021

Poster presentation to address the preclinical cannabidiol derivative for the potential treatment of psychiatric disorders BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. Nasdaq:… Read More.

Pharmaceutical 98

Pharmaceutical Data Medicine Treatment 98

Cannabis Law Report

DECEMBER 27, 2019

If you thought there was no relationship between cannabis use and technology, consider these stats: the average number of mobile apps being used in a day by current cannabis users are 4. Clinical trials are medical research projects involving human participants. Authored By : Arundati Dandapani.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

Cannabis Law Report

FEBRUARY 10, 2022

The industry’s fundamentals remain strong, and we firmly believe that 2022 will be another breakthrough year for the cannabis industry. Gary Allen, CEO, New Frontier Data. Germany’s intent to legalize adult-use cannabis, we expect several U.S. cannabis market opportunity. Key Findings: U.S. Global Expansion: With?Germany’s

Data 52

Data Research and Development Hemp Legalization 52

Veriheal

NOVEMBER 30, 2021

Veriheal does not support illegally consuming therapeutic substances such as psilocybin but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies.

Research and Development 98

Research and Development Therapy Data Treatment 98

Cannabis Law Report

JUNE 4, 2021

Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021. The post AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591 appeared first on CannabisFN. Phase 2 trial underway.

Data 100

Data Research and Development Clinical Trials Therapy 100

The Cannigma

JANUARY 16, 2021

Listen & Subscribe: Finding the right cannabis product can be a daunting task for anyone, let alone a new medical patient without any guidance. “That’s not really available in the cannabis industry,” he explained on the Cannabis Enigma podcast. Produced by Elana Goldberg and Michael Schaeffer Omer-Man.

Data 100

Data Research and Development Patients Strains 100

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Today, databases, predictive analytics, artificial intelligence , and machine learning are having widespread effects on cannabis businesses, investors, regulators, and consumers. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

Cannabis Law Report

JULY 27, 2021

The initiative is part of Project Change Lives; Clever Leaves’ $25M product pledge to aid cannabis research in the U.S. The collaboration represents the Company’s first funded study with a research institution in the United States. NEW YORK, July 27, 2021 — Clever Leaves Holdings Inc.

Research and Development 98

Research and Development Pharmaceutical Sativa Extraction 98

Veriheal

NOVEMBER 13, 2020

Until recently, there has been little to no research available that examines the effects of cannabis in patients diagnosed with Obsessive-Compulsive Disorder (OCD). Perhaps cannabis can be used to bring back some of that control for OCD patients. . What Does Research Say About Cannabis and OCD?

Research and Development 98

Research and Development Consumption Patients Strains 98

Cannabis Law Report

JULY 8, 2021

(NYSE American: YCBD, YCBDpA), one of the leading, and most highly trusted and recognized CBD companies, announced today that its recently formed division, cbdMD Therapeutics, has initiated talks with one of the leading US cannabinoid research institutes, to identify novel cannabinoids for therapeutic use. About cbdMD, Inc. cbdMD, Inc.

Research and Development 111

Research and Development Pets Cannabinoids eCommerce 111

SpeedWeed

MAY 18, 2021

Drug Enforcement Administration (DEA) quietly made an announcement that’s expected to have a profound and long-lasting impact on cannabis research and development in the United States. In other words, the feds are ending their monopoly on cannabis grown for scientific purposes. cannabis researchers.

DEA 52

DEA Research and Development Data Cannabis 52

SpeedWeed

APRIL 2, 2021

Prohibitionists and fear-mongering media outlets often try to discourage popular support for cannabis reform by claiming that underage cannabis use can cause brain damage. Some of these claims were based on outdated research, but scientists are now discovering that alcohol , not weed, is responsible for these developmental issues.

Research and Development 52

Research and Development History Media Collective 52

Cannabis Law Report

NOVEMBER 2, 2021

Earlier this month, the FDA released a seven-page plan to accelerate its research into the safety of cannabis-derived products. Piloting market surveillance tools to monitor unapproved cannabis-derived products and “identify potential safety issues before the issues become mainstream.” 01 November 2021.

Safety 52

Safety Data Supply Chain Research and Development 52

Veriheal

FEBRUARY 19, 2021

Cannabis in America is stuck in a catch-22 situation of epic proportions. The lack of research is one of the many reasons that cannabis remains federally illegal. But one of the barriers to conducting the necessary research is its federally illegal status. Fraud Plagues the Cannabis Industry.

Legalization 89

Legalization Research and Development Safety Data 89

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

Cannabis Law Report

MAY 29, 2022

is a Canadian company that researches, develops and grows psilocybin-producing mushrooms and functional mushrooms. Ciprick said there needs to be more outcome data and studies on the psilocybin-producing mushrooms to give that comfort level heading forward into introducing a larger market for the product. Optimi Health Corp.

Research and Development 52

Research and Development Clinical Trials Medicine Access 52

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

AUGUST 30, 2021

The gene, designated PM1 , is the first pathogen resistance gene in cannabis to be formally characterized. The newly published paper in Frontiers in Agronomy describes a promising first step toward reducing pesticide use on cannabis farms. Mihalyov, PhD and Oregon CBD Director of Research & Development Andrea R.

Research and Development 103

Research and Development Sativa Agriculture Cultivation 103

Cannabis Law Report

JANUARY 7, 2022

Our NXTecK™ platform is introducing scalable, aggregated, and normalized consumer data with an attribution model, so you know exactly where and how to focus your multi-channel strategies and achieve your digital marketing goals. Free Access to Equio ®. Sponsorship and Marketing Offerings.

Data 52

Data Research and Development Access Retail 52

Cannabis Law Report

JULY 7, 2021

New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. MYMD-1 is being developed to treat autoimmune and age-related diseases, and to slow aging thereby increasing life-span. Acumen Research and Consulting confirmed TNF-? President, Director and Chief Medical Officer of MyMD.

Pharmaceutical 105

Pharmaceutical Data Clinical Trials Research and Development 105

Cannabis Law Report

APRIL 19, 2019

A female CEO of a cannabis research company is fighting back against controversial Marijuana investor Andy Defrancesco after he started a twitter campaign to allegedly disparage her company and her personal ethics as a CEO. Read on at … Sol Global Chairman Andy Defrancesco sued for Defamation by Cannabis Research Firm: $SOLCF.

Research and Development 61

Research and Development Data Media Banking 61

Cannabis Law Report

OCTOBER 10, 2019

Zefyr Inc , a data analytics firm described in a news announcement as the “Nielsen” of cannabis. Cannabis Big Data Firm to Acquire Zefyr, the ‘Alexa’ of Cannabis. New Frontier Data to Launch Joint Marketing Tech Offering for Mature Market Entrants. Here’s the PR. October 9, 2019.

Data 40

Data Research and Development Business Policy 40

Cannabis Law Report

JULY 19, 2021

The data from the study is expected to be embedded into the RYAH MD platform, with the goal of enabling healthcare professionals to administer THC, CBD and terpenes in milliliters, which are then expected to automatically be converted into milligrams to allow for a customized, targeted patient inhalation session. “Our

Therapy 76

Therapy Data Research and Development Events 76

Cannabis Law Report

JULY 29, 2021

Scientists and researchers do not know exactly how or why these negative results occur, but they are still working on the question. HPPD is most commonly caused by LSD and Mushrooms, but also can be caused by MDMA, Cannabis, and even SSRIs. Some people have different flashback experience. Forward-Looking Statement Disclaimer.

Research and Development 105

Research and Development Conditions Data Patients 105

Veriheal

NOVEMBER 21, 2023

Veriheal remains dedicated to supporting the next generation of pioneers through its Innovation in Cannabis Scholarship. This year, we are proud to continue our investment in the next generation of cannabis industry leaders. Their one-of-a-kind innovations and solutions are invaluable to the future of cannabis.

Research and Development 107

Research and Development Consumption Education Data 107

Veriheal

JUNE 27, 2023

Scientists at the University Of California have found cannabis smokers less susceptible to COPD than tobacco users. Titled Impact of Marijuana Smoking on COPD Progression in a Cohort of Middle-Aged and Older Persons , the study compared active marijuana smokers, one-time cannabis smokers, and those who never smoked weed.

Research and Development 104

Research and Development Data Collective Vaping 104

Cannabis Law Report

APRIL 28, 2022

Rather than just accept the fact that the general public might be smart enough to see that the war on drugs and especially cannabis is quite simply stupid, instead a better solution !!, Get a bunch of researchers to research it, publish a report for committees to mull over and then ignore. the researchers went on to state.

Legalization 52

Legalization Research and Development Media Data 52

Cannabis Law Report

MARCH 9, 2022

This license expansion will further position Numinus as a recognized global research centre for natural psychedelic medicines, and supplements the current work Numinus is already undertaking on Psilocybe species and inherent synergistic compounds. Harmaline and harmalol naturally occur in B. caapi , while P. viridis , D.

Research and Development 52

Research and Development Therapy Access Medicine 52

Cannabis Law Report

JANUARY 19, 2022

Aligning with the leading market data industry trends in analytical financial services, DeFi, and Index Management allowed the firm to boost its revenue by 45% during 2021, continuing the trend of annual double-digit growth totaling over 560% since 2016. We plan to continue developing our analytical services line. About dxFeed.

Data 52

Data Research and Development Retail Business 52